-
1
-
-
78651386028
-
Left ventricular remodeling in heart failure: Current concepts in clinical significance and assessment
-
Konstam MA, Kramer DG, Patel AR, Maron MS, Udelson JE. Left ventricular remodeling in heart failure: current concepts in clinical significance and assessment. J Am Coll Cardiol. 2011;4:98-108.
-
(2011)
J Am Coll Cardiol
, vol.4
, pp. 98-108
-
-
Konstam, M.A.1
Kramer, D.G.2
Patel, A.R.3
Maron, M.S.4
Udelson, J.E.5
-
2
-
-
0342804535
-
Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: Significance of left ventricular hypertrophy
-
Studies of Left Ventricular Dysfunction
-
Quiñones MA, Greenberg BH, Kopelen HA, Koilpillai C, Limacher MC, Shindler DM, Shelton BJ, Weiner DH. Echocardiographic predictors of clinical outcome in patients with left ventricular dysfunction enrolled in the SOLVD registry and trials: significance of left ventricular hypertrophy. Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 2000;35:1237-1244.
-
(2000)
J Am Coll Cardiol
, vol.35
, pp. 1237-1244
-
-
Quiñones, M.A.1
Greenberg, B.H.2
Kopelen, H.A.3
Koilpillai, C.4
Limacher, M.C.5
Shindler, D.M.6
Shelton, B.J.7
Weiner, D.H.8
-
3
-
-
84874285627
-
Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation
-
Ma Y, Halade GV, Zhang J, Ramirez TA, Levin D, Voorhees A, Jin Y, Han H, Manicone AM, Lindsey ML. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ Res. 2013:112:675-688.
-
(2013)
Circ Res
, vol.112
, pp. 675-688
-
-
Ma, Y.1
Halade, G.V.2
Zhang, J.3
Ramirez, T.A.4
Levin, D.5
Voorhees, A.6
Jin, Y.7
Han, H.8
Manicone, A.M.9
Lindsey, M.L.10
-
4
-
-
0345935809
-
Collagenolytic activity in amphibian tissues: A tissue culture assay
-
Gross J, Lapiere CM. Collagenolytic activity in amphibian tissues: a tissue culture assay. Proc Natl Acad Sci USA. 1962;48:1014-1022.
-
(1962)
Proc Natl Acad Sci USA
, vol.48
, pp. 1014-1022
-
-
Gross, J.1
Lapiere, C.M.2
-
5
-
-
14644435713
-
Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice
-
Matsumura S, Iwanaga S, Mochizuki S, Okamoto H, Ogawa S, Okada Y. Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice. J Clin Invest. 2005;115:599-609.
-
(2005)
J Clin Invest
, vol.115
, pp. 599-609
-
-
Matsumura, S.1
Iwanaga, S.2
Mochizuki, S.3
Okamoto, H.4
Ogawa, S.5
Okada, Y.6
-
6
-
-
0033932709
-
Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction
-
Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000;106:55-62.
-
(2000)
J Clin Invest
, vol.106
, pp. 55-62
-
-
Ducharme, A.1
Frantz, S.2
Aikawa, M.3
Rabkin, E.4
Lindsey, M.5
Rohde, L.E.6
Schoen, F.J.7
Kelly, R.A.8
Werb, Z.9
Libby, P.10
Lee, R.T.11
-
7
-
-
33747131851
-
Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction
-
Lindsey ML, Escobar GP, Mukherjee R, Goshorn DK, Sheats NJ, Bruce JA, Mains IM, Hendrick JK, Hewett KW, Gourdie RG, Matrisian LM, Spinale FG. Matrix metalloproteinase-7 affects connexin-43 levels, electrical conduction, and survival after myocardial infarction. Circulation. 2006;113:2919-2928.
-
(2006)
Circulation
, vol.113
, pp. 2919-2928
-
-
Lindsey, M.L.1
Escobar, G.P.2
Mukherjee, R.3
Goshorn, D.K.4
Sheats, N.J.5
Bruce, J.A.6
Mains, I.M.7
Hendrick, J.K.8
Hewett, K.W.9
Gourdie, R.G.10
Matrisian, L.M.11
Spinale, F.G.12
-
8
-
-
77956914017
-
Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction
-
Spinale FG, Mukherjee R, Zavadzkas JA, Koval CN, Bouges S, Stroud RE, Dobrucki LW, Sinusas AJ. Cardiac restricted overexpression of membrane type-1 matrix metalloproteinase causes adverse myocardial remodeling following myocardial infarction. J Biol Chem. 2010;285:30316-30327.
-
(2010)
J Biol Chem
, vol.285
, pp. 30316-30327
-
-
Spinale, F.G.1
Mukherjee, R.2
Zavadzkas, J.A.3
Koval, C.N.4
Bouges, S.5
Stroud, R.E.6
Dobrucki, L.W.7
Sinusas, A.J.8
-
9
-
-
84867403208
-
Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction
-
Zamilpa R, Ibarra J, de Castro Brás LE, Ramirez TA, Nguyen N, Halade GV, Zhang J, Dai Q, Dayah T, Chiao YA, Lowell W, Ahuja SS, D'Armiento J, Jin YF, Lindsey ML. Transgenic overexpression of matrix metalloproteinase-9 in macrophages attenuates the inflammatory response and improves left ventricular function post-myocardial infarction. J Mol Cell Cardiol. 2012;53:599-608.
-
(2012)
J Mol Cell Cardiol
, vol.53
, pp. 599-608
-
-
Zamilpa, R.1
Ibarra, J.2
De Castro Brás, L.E.3
Ramirez, T.A.4
Nguyen, N.5
Halade, G.V.6
Zhang, J.7
Dai, Q.8
Dayah, T.9
Chiao, Y.A.10
Lowell, W.11
Ahuja, S.S.12
D'Armiento, J.13
Jin, Y.F.14
Lindsey, M.L.15
-
10
-
-
72749114050
-
Updated biological roles for matrix metalloproteinases and new intracellular" substrates revealed by degradomics
-
Butler GS, Overall CM. Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics. Biochemistry. 2009;48:10830-10845.
-
(2009)
Biochemistry
, vol.48
, pp. 10830-10845
-
-
Butler, G.S.1
Overall, C.M.2
-
11
-
-
77149164774
-
Matrix metalloproteinases: What do they not do? New substrates and biological roles identified by murine models and proteomics
-
Rodríguez D, Morrison CJ, Overall CM. Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. Biochim Biophys Acta. 2010;1803: 39-54.
-
(2010)
Biochim Biophys Acta
, vol.1803
, pp. 39-54
-
-
Rodríguez, D.1
Morrison, C.J.2
Overall, C.M.3
-
12
-
-
77950931419
-
Matrix metalloproteinases: Regulators of the tumor microenvironment
-
Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell. 2010;141:52-67.
-
(2010)
Cell
, vol.141
, pp. 52-67
-
-
Kessenbrock, K.1
Plaks, V.2
Werb, Z.3
-
13
-
-
77956301181
-
Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
-
Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 2010;20:161-168.
-
(2010)
Semin Cancer Biol
, vol.20
, pp. 161-168
-
-
Bourboulia, D.1
Stetler-Stevenson, W.G.2
-
14
-
-
84860830113
-
Epithelial-mesenchymal transition: General principles and pathological relevance with special emphasis on the role of matrix metalloproteinases
-
Nisticò P, Bissell MJ, Radisky DC. Epithelial-mesenchymal transition: general principles and pathological relevance with special emphasis on the role of matrix metalloproteinases. Cold Spring Harb Perspect Biol. 2012;4:a011908.
-
(2012)
Cold Spring Harb Perspect Biol
, vol.4
-
-
Nisticò, P.1
Bissell, M.J.2
Radisky, D.C.3
-
15
-
-
79957476831
-
MMP28 (epilysin) as a novel promoter of invasion and metastasis in gastric cancer
-
Jian P, Yanfang T, Zhuan Z, Jian W, Xueming Z, Jian N. MMP28 (epilysin) as a novel promoter of invasion and metastasis in gastric cancer. BMC Cancer. 2011;11:200.
-
(2011)
BMC Cancer
, vol.11
, pp. 200
-
-
Jian, P.1
Yanfang, T.2
Zhuan, Z.3
Jian, W.4
Xueming, Z.5
Jian, N.6
-
16
-
-
33750330614
-
Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells
-
Illman SA, Lehti K, Keski-Oja J, Lohi J. Epilysin (MMP-28) induces TGF-beta mediated epithelial to mesenchymal transition in lung carcinoma cells. J Cell Sci. 2006;119:3856-3865.
-
(2006)
J Cell Sci
, vol.119
, pp. 3856-3865
-
-
Illman, S.A.1
Lehti, K.2
Keski-Oja, J.3
Lohi, J.4
-
17
-
-
54049130859
-
Epilysin (MMP-28)-structure, expression and potential functions
-
Illman SA, Lohi J, Keski-Oja J. Epilysin (MMP-28)-structure, expression and potential functions. Exp Dermatol. 2008;17:897-907.
-
(2008)
Exp Dermatol
, vol.17
, pp. 897-907
-
-
Illman, S.A.1
Lohi, J.2
Keski-Oja, J.3
-
18
-
-
67649344123
-
Expression and function of matrix metalloproteinase (MMP)-28
-
Rodgers UR, Kevorkian L, Surridge AK, Waters JG, Swingler TE, Culley K, Illman S, Lohi J, Parker AE, Clark IM. Expression and function of matrix metalloproteinase (MMP)-28. Matrix Biol. 2009;28:263-272.
-
(2009)
Matrix Biol
, vol.28
, pp. 263-272
-
-
Rodgers, U.R.1
Kevorkian, L.2
Surridge, A.K.3
Waters, J.G.4
Swingler, T.E.5
Culley, K.6
Illman, S.7
Lohi, J.8
Parker, A.E.9
Clark, I.M.10
-
19
-
-
65449133169
-
Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia
-
Manicone AM, Birkland TP, Lin M, Betsuyaku T, van Rooijen N, Lohi J, Keski-Oja J, Wang Y, Skerrett SJ, Parks WC. Epilysin (MMP-28) restrains early macrophage recruitment in Pseudomonas aeruginosa pneumonia. J Immunol. 2009;182:3866-3876.
-
(2009)
J Immunol
, vol.182
, pp. 3866-3876
-
-
Manicone, A.M.1
Birkland, T.P.2
Lin, M.3
Betsuyaku, T.4
Van Rooijen, N.5
Lohi, J.6
Keski-Oja, J.7
Wang, Y.8
Skerrett, S.J.9
Parks, W.C.10
-
20
-
-
78650764256
-
Furin Functions as a Nonproteolytic Chaperone for Matrix Metalloproteinase-28: MMP-28 Propeptide Sequence Requirement
-
Pavlaki M, Zucker S, Dufour A, Calabrese N, Bahou W, Cao J. Furin Functions as a Nonproteolytic Chaperone for Matrix Metalloproteinase-28: MMP-28 Propeptide Sequence Requirement. Biochem Res Int. 2011;2011:630319.
-
(2011)
Biochem Res Int
, vol.2011
, pp. 630319
-
-
Pavlaki, M.1
Zucker, S.2
Dufour, A.3
Calabrese, N.4
Bahou, W.5
Cao, J.6
-
21
-
-
84855371090
-
Regulation of the inflammatory response in cardiac repair
-
Frangogiannis NG. Regulation of the inflammatory response in cardiac repair. Circ Res. 2012;110:159-173.
-
(2012)
Circ Res
, vol.110
, pp. 159-173
-
-
Frangogiannis, N.G.1
-
22
-
-
34547676391
-
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
-
Zeisberg EM, Tarnavski O, Zeisberg M, Dorfman AL, McMullen JR, Gustafsson E, Chandraker A, Yuan X, Pu WT, Roberts AB, Neilson EG, Sayegh MH, Izumo S, Kalluri R. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007;13:952-961.
-
(2007)
Nat Med
, vol.13
, pp. 952-961
-
-
Zeisberg, E.M.1
Tarnavski, O.2
Zeisberg, M.3
Dorfman, A.L.4
McMullen, J.R.5
Gustafsson, E.6
Chandraker, A.7
Yuan, X.8
Pu, W.T.9
Roberts, A.B.10
Neilson, E.G.11
Sayegh, M.H.12
Izumo, S.13
Kalluri, R.14
-
23
-
-
84862274773
-
Transcriptional and post-transcriptional regulation in TGF-Â-mediated epithelial-mesenchymal transition
-
Saitoh M, Miyazawa K. Transcriptional and post-transcriptional regulation in TGF-â-mediated epithelial-mesenchymal transition. J Biochem. 2012;151:563-571.
-
(2012)
J Biochem
, vol.151
, pp. 563-571
-
-
Saitoh, M.1
Miyazawa, K.2
-
24
-
-
84856213276
-
LIM-domain proteins in transforming growth factor â-induced epithelial-to-mesenchymal transition and myofibroblast differentiation
-
Järvinen PM, Laiho M. LIM-domain proteins in transforming growth factor â-induced epithelial-to-mesenchymal transition and myofibroblast differentiation. Cell Signal. 2012;24:819-825.
-
(2012)
Cell Signal
, vol.24
, pp. 819-825
-
-
Järvinen, P.M.1
Laiho, M.2
-
25
-
-
47349086991
-
MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1
-
Tatti O, Vehviläinen P, Lehti K, Keski-Oja J. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. Exp Cell Res. 2008;314:2501-2514.
-
(2008)
Exp Cell Res
, vol.314
, pp. 2501-2514
-
-
Tatti, O.1
Vehviläinen, P.2
Lehti, K.3
Keski-Oja, J.4
-
26
-
-
33745282396
-
Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: Results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial
-
Hudson MP, Armstrong PW, Ruzyllo W, Brum J, Cusmano L, Krzeski P, Lyon R, Quinones M, Theroux P, Sydlowski D, Kim HE, Garcia MJ, Jaber WA, Weaver WD. Effects of selective matrix metalloproteinase inhibitor (PG-116800) to prevent ventricular remodeling after myocardial infarction: results of the PREMIER (Prevention of Myocardial Infarction Early Remodeling) trial. J Am Coll Cardiol. 2006;48:15-20.
-
(2006)
J Am Coll Cardiol
, vol.48
, pp. 15-20
-
-
Hudson, M.P.1
Armstrong, P.W.2
Ruzyllo, W.3
Brum, J.4
Cusmano, L.5
Krzeski, P.6
Lyon, R.7
Quinones, M.8
Theroux, P.9
Sydlowski, D.10
Kim, H.E.11
Garcia, M.J.12
Jaber, W.A.13
Weaver, W.D.14
|